Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system
Identifieur interne : 000121 ( PascalFrancis/Checkpoint ); précédent : 000120; suivant : 000122Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system
Auteurs : Maria Xilouri [Grèce] ; Elli Kyratzi [Grèce] ; Pothitos M. Pitychoutis [Grèce] ; Zoi Papadopoulou-Daifoti [Grèce] ; Celine Perier [Espagne] ; Miquel Vila [Espagne] ; Matina Maniati [Grèce] ; Ayse Ulusoy [Suède] ; Deniz Kirik [Suède] ; David S. Park [Canada] ; Keiji Wada [Japon] ; Leonidas Stefanis [Grèce]Source :
- Human molecular genetics : (Print) [ 0964-6906 ] ; 2012.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Génétique.
English descriptors
- KwdEn :
Abstract
Genetic studies have implicated the neuronal ubiquitin C-terminal hydrolase (UCH) protein UCH-L1 in Parkinson's disease (PD) pathogenesis. Moreover, the function of UCH-L1 may be lost in the brains of PD and Alzheimer's disease patients. We have previously reported that the UCH-L1 polymorphic variant S18Y, potentially protective against PD in population studies, demonstrates specific antioxidant functions in cell culture. Albeit genetic, biochemical and neuropathological data support an association between UCH-L1, PD, synaptic degeneration and oxidative stress, the relationship between the dopaminergic system and UCH-L1 status remains obscure. In the current study, we have examined the dopaminergic system of mice lacking endogenous UCH-L1 protein (gracile axonal dystrophy mice). Our findings show that the lack of wild-type (WT) UCH-L1 does not influence to any significant degree the dopaminergic system at baseline or following injections of the neurotoxin methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Furthermore, using a novel intrastriatal adenoviral injection protocol, we have found that mouse nigral neurons retrogradely transduced with S18Y UCH-L1, but not the WT protein, are significantly protected against MPTP toxicity. Overall, these data provide evidence for an antioxidant and neuroprotective effect of the S18Y variant of UCH-L1, but not of the WT protein, in the dopaminergic system, and may have implications for the pathogenesis of PD or related neurodegenerative conditions, in which oxidative stress might play a role.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:12-0122767Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system</title><author><name sortKey="Xilouri, Maria" sort="Xilouri, Maria" uniqKey="Xilouri M" first="Maria" last="Xilouri">Maria Xilouri</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ><sZ>12 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Kyratzi, Elli" sort="Kyratzi, Elli" uniqKey="Kyratzi E" first="Elli" last="Kyratzi">Elli Kyratzi</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ><sZ>12 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Pitychoutis, Pothitos M" sort="Pitychoutis, Pothitos M" uniqKey="Pitychoutis P" first="Pothitos M." last="Pitychoutis">Pothitos M. Pitychoutis</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmacology, Medical School, University of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Papadopoulou Daifoti, Zoi" sort="Papadopoulou Daifoti, Zoi" uniqKey="Papadopoulou Daifoti Z" first="Zoi" last="Papadopoulou-Daifoti">Zoi Papadopoulou-Daifoti</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmacology, Medical School, University of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Perier, Celine" sort="Perier, Celine" uniqKey="Perier C" first="Celine" last="Perier">Celine Perier</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)</s1><s2>Barcelona 08035</s2><s3>ESP</s3><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Vila, Miquel" sort="Vila, Miquel" uniqKey="Vila M" first="Miquel" last="Vila">Miquel Vila</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)</s1><s2>Barcelona 08035</s2><s3>ESP</s3><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Catalan Institution for Research and Advanced Studies (ICREA)</s1><s2>08010 Barcelona</s2><s3>ESP</s3><sZ>6 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="05"><s1>Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona</s1><s2>08193 Bellaterra, Barcelona</s2><s3>ESP</s3><sZ>6 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Maniati, Matina" sort="Maniati, Matina" uniqKey="Maniati M" first="Matina" last="Maniati">Matina Maniati</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ><sZ>12 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Ulusoy, Ayse" sort="Ulusoy, Ayse" uniqKey="Ulusoy A" first="Ayse" last="Ulusoy">Ayse Ulusoy</name><affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Brain Repair and Imaging in Neural Systems, Department of Experimental Medical Science, Lund University</s1><s2>Lund</s2><s3>SWE</s3><sZ>8 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>Suède</country><wicri:noRegion>Lund</wicri:noRegion></affiliation></author><author><name sortKey="Kirik, Deniz" sort="Kirik, Deniz" uniqKey="Kirik D" first="Deniz" last="Kirik">Deniz Kirik</name><affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Brain Repair and Imaging in Neural Systems, Department of Experimental Medical Science, Lund University</s1><s2>Lund</s2><s3>SWE</s3><sZ>8 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>Suède</country><wicri:noRegion>Lund</wicri:noRegion></affiliation></author><author><name sortKey="Park, David S" sort="Park, David S" uniqKey="Park D" first="David S." last="Park">David S. Park</name><affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Neuroscience Lab, University of Ottawa</s1><s2>Ottawa, ON</s2><s3>CAN</s3><sZ>10 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Ottawa, ON</wicri:noRegion></affiliation></author><author><name sortKey="Wada, Keiji" sort="Wada, Keiji" uniqKey="Wada K" first="Keiji" last="Wada">Keiji Wada</name><affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry</s1><s2>Tokyo 187-8502</s2><s3>JPN</s3><sZ>11 aut.</sZ></inist:fA14><country>Japon</country><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Stefanis, Leonidas" sort="Stefanis, Leonidas" uniqKey="Stefanis L" first="Leonidas" last="Stefanis">Leonidas Stefanis</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ><sZ>12 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Second Department of Neurology, University of Athens Medical School</s1><s2>Athens</s2><s3>GRC</s3><sZ>12 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">12-0122767</idno><date when="2012">2012</date><idno type="stanalyst">PASCAL 12-0122767 INIST</idno><idno type="RBID">Pascal:12-0122767</idno><idno type="wicri:Area/PascalFrancis/Corpus">000219</idno><idno type="wicri:Area/PascalFrancis/Curation">000A33</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000121</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000121</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system</title><author><name sortKey="Xilouri, Maria" sort="Xilouri, Maria" uniqKey="Xilouri M" first="Maria" last="Xilouri">Maria Xilouri</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ><sZ>12 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Kyratzi, Elli" sort="Kyratzi, Elli" uniqKey="Kyratzi E" first="Elli" last="Kyratzi">Elli Kyratzi</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ><sZ>12 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Pitychoutis, Pothitos M" sort="Pitychoutis, Pothitos M" uniqKey="Pitychoutis P" first="Pothitos M." last="Pitychoutis">Pothitos M. Pitychoutis</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmacology, Medical School, University of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Papadopoulou Daifoti, Zoi" sort="Papadopoulou Daifoti, Zoi" uniqKey="Papadopoulou Daifoti Z" first="Zoi" last="Papadopoulou-Daifoti">Zoi Papadopoulou-Daifoti</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmacology, Medical School, University of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Perier, Celine" sort="Perier, Celine" uniqKey="Perier C" first="Celine" last="Perier">Celine Perier</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)</s1><s2>Barcelona 08035</s2><s3>ESP</s3><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Vila, Miquel" sort="Vila, Miquel" uniqKey="Vila M" first="Miquel" last="Vila">Miquel Vila</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)</s1><s2>Barcelona 08035</s2><s3>ESP</s3><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Catalan Institution for Research and Advanced Studies (ICREA)</s1><s2>08010 Barcelona</s2><s3>ESP</s3><sZ>6 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="05"><s1>Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona</s1><s2>08193 Bellaterra, Barcelona</s2><s3>ESP</s3><sZ>6 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Maniati, Matina" sort="Maniati, Matina" uniqKey="Maniati M" first="Matina" last="Maniati">Matina Maniati</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ><sZ>12 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Ulusoy, Ayse" sort="Ulusoy, Ayse" uniqKey="Ulusoy A" first="Ayse" last="Ulusoy">Ayse Ulusoy</name><affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Brain Repair and Imaging in Neural Systems, Department of Experimental Medical Science, Lund University</s1><s2>Lund</s2><s3>SWE</s3><sZ>8 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>Suède</country><wicri:noRegion>Lund</wicri:noRegion></affiliation></author><author><name sortKey="Kirik, Deniz" sort="Kirik, Deniz" uniqKey="Kirik D" first="Deniz" last="Kirik">Deniz Kirik</name><affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Brain Repair and Imaging in Neural Systems, Department of Experimental Medical Science, Lund University</s1><s2>Lund</s2><s3>SWE</s3><sZ>8 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>Suède</country><wicri:noRegion>Lund</wicri:noRegion></affiliation></author><author><name sortKey="Park, David S" sort="Park, David S" uniqKey="Park D" first="David S." last="Park">David S. Park</name><affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Neuroscience Lab, University of Ottawa</s1><s2>Ottawa, ON</s2><s3>CAN</s3><sZ>10 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Ottawa, ON</wicri:noRegion></affiliation></author><author><name sortKey="Wada, Keiji" sort="Wada, Keiji" uniqKey="Wada K" first="Keiji" last="Wada">Keiji Wada</name><affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry</s1><s2>Tokyo 187-8502</s2><s3>JPN</s3><sZ>11 aut.</sZ></inist:fA14><country>Japon</country><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Stefanis, Leonidas" sort="Stefanis, Leonidas" uniqKey="Stefanis L" first="Leonidas" last="Stefanis">Leonidas Stefanis</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ><sZ>12 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Second Department of Neurology, University of Athens Medical School</s1><s2>Athens</s2><s3>GRC</s3><sZ>12 aut.</sZ></inist:fA14><country>Grèce</country><wicri:noRegion>Athens</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Human molecular genetics : (Print)</title><title level="j" type="abbreviated">Hum. mol. genet. : (Print)</title><idno type="ISSN">0964-6906</idno><imprint><date when="2012">2012</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Human molecular genetics : (Print)</title><title level="j" type="abbreviated">Hum. mol. genet. : (Print)</title><idno type="ISSN">0964-6906</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Genetic variability</term><term>Genetics</term><term>Genotype</term><term>Neuroprotection</term><term>Polymorphism</term><term>Variant</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Neuroprotection</term><term>Polymorphisme</term><term>Variant</term><term>Variabilité génétique</term><term>Génotype</term><term>Génétique</term><term>Ubiquitin carboxy-terminal hydrolase L1</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Génétique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Genetic studies have implicated the neuronal ubiquitin C-terminal hydrolase (UCH) protein UCH-L1 in Parkinson's disease (PD) pathogenesis. Moreover, the function of UCH-L1 may be lost in the brains of PD and Alzheimer's disease patients. We have previously reported that the UCH-L1 polymorphic variant S18Y, potentially protective against PD in population studies, demonstrates specific antioxidant functions in cell culture. Albeit genetic, biochemical and neuropathological data support an association between UCH-L1, PD, synaptic degeneration and oxidative stress, the relationship between the dopaminergic system and UCH-L1 status remains obscure. In the current study, we have examined the dopaminergic system of mice lacking endogenous UCH-L1 protein (gracile axonal dystrophy mice). Our findings show that the lack of wild-type (WT) UCH-L1 does not influence to any significant degree the dopaminergic system at baseline or following injections of the neurotoxin methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Furthermore, using a novel intrastriatal adenoviral injection protocol, we have found that mouse nigral neurons retrogradely transduced with S18Y UCH-L1, but not the WT protein, are significantly protected against MPTP toxicity. Overall, these data provide evidence for an antioxidant and neuroprotective effect of the S18Y variant of UCH-L1, but not of the WT protein, in the dopaminergic system, and may have implications for the pathogenesis of PD or related neurodegenerative conditions, in which oxidative stress might play a role.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0964-6906</s0></fA01><fA03 i2="1"><s0>Hum. mol. genet. : (Print)</s0></fA03><fA05><s2>21</s2></fA05><fA06><s2>4</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system</s1></fA08><fA11 i1="01" i2="1"><s1>XILOURI (Maria)</s1></fA11><fA11 i1="02" i2="1"><s1>KYRATZI (Elli)</s1></fA11><fA11 i1="03" i2="1"><s1>PITYCHOUTIS (Pothitos M.)</s1></fA11><fA11 i1="04" i2="1"><s1>PAPADOPOULOU-DAIFOTI (Zoi)</s1></fA11><fA11 i1="05" i2="1"><s1>PERIER (Celine)</s1></fA11><fA11 i1="06" i2="1"><s1>VILA (Miquel)</s1></fA11><fA11 i1="07" i2="1"><s1>MANIATI (Matina)</s1></fA11><fA11 i1="08" i2="1"><s1>ULUSOY (Ayse)</s1></fA11><fA11 i1="09" i2="1"><s1>KIRIK (Deniz)</s1></fA11><fA11 i1="10" i2="1"><s1>PARK (David S.)</s1></fA11><fA11 i1="11" i2="1"><s1>WADA (Keiji)</s1></fA11><fA11 i1="12" i2="1"><s1>STEFANIS (Leonidas)</s1></fA11><fA14 i1="01"><s1>Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ><sZ>12 aut.</sZ></fA14><fA14 i1="02"><s1>Department of Pharmacology, Medical School, University of Athens</s1><s2>Athens</s2><s3>GRC</s3><sZ>3 aut.</sZ><sZ>4 aut.</sZ></fA14><fA14 i1="03"><s1>Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)</s1><s2>Barcelona 08035</s2><s3>ESP</s3><sZ>5 aut.</sZ><sZ>6 aut.</sZ></fA14><fA14 i1="04"><s1>Catalan Institution for Research and Advanced Studies (ICREA)</s1><s2>08010 Barcelona</s2><s3>ESP</s3><sZ>6 aut.</sZ></fA14><fA14 i1="05"><s1>Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona</s1><s2>08193 Bellaterra, Barcelona</s2><s3>ESP</s3><sZ>6 aut.</sZ></fA14><fA14 i1="06"><s1>Brain Repair and Imaging in Neural Systems, Department of Experimental Medical Science, Lund University</s1><s2>Lund</s2><s3>SWE</s3><sZ>8 aut.</sZ><sZ>9 aut.</sZ></fA14><fA14 i1="07"><s1>Neuroscience Lab, University of Ottawa</s1><s2>Ottawa, ON</s2><s3>CAN</s3><sZ>10 aut.</sZ></fA14><fA14 i1="08"><s1>Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry</s1><s2>Tokyo 187-8502</s2><s3>JPN</s3><sZ>11 aut.</sZ></fA14><fA14 i1="09"><s1>Second Department of Neurology, University of Athens Medical School</s1><s2>Athens</s2><s3>GRC</s3><sZ>12 aut.</sZ></fA14><fA20><s1>874-889</s1></fA20><fA21><s1>2012</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>22540</s2><s5>354000508403300130</s5></fA43><fA44><s0>0000</s0><s1>© 2012 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>66 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>12-0122767</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Human molecular genetics : (Print)</s0></fA64><fA66 i1="01"><s0>GBR</s0></fA66><fC01 i1="01" l="ENG"><s0>Genetic studies have implicated the neuronal ubiquitin C-terminal hydrolase (UCH) protein UCH-L1 in Parkinson's disease (PD) pathogenesis. Moreover, the function of UCH-L1 may be lost in the brains of PD and Alzheimer's disease patients. We have previously reported that the UCH-L1 polymorphic variant S18Y, potentially protective against PD in population studies, demonstrates specific antioxidant functions in cell culture. Albeit genetic, biochemical and neuropathological data support an association between UCH-L1, PD, synaptic degeneration and oxidative stress, the relationship between the dopaminergic system and UCH-L1 status remains obscure. In the current study, we have examined the dopaminergic system of mice lacking endogenous UCH-L1 protein (gracile axonal dystrophy mice). Our findings show that the lack of wild-type (WT) UCH-L1 does not influence to any significant degree the dopaminergic system at baseline or following injections of the neurotoxin methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Furthermore, using a novel intrastriatal adenoviral injection protocol, we have found that mouse nigral neurons retrogradely transduced with S18Y UCH-L1, but not the WT protein, are significantly protected against MPTP toxicity. Overall, these data provide evidence for an antioxidant and neuroprotective effect of the S18Y variant of UCH-L1, but not of the WT protein, in the dopaminergic system, and may have implications for the pathogenesis of PD or related neurodegenerative conditions, in which oxidative stress might play a role.</s0></fC01><fC02 i1="01" i2="X"><s0>002A04</s0></fC02><fC02 i1="02" i2="X"><s0>002A07</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Neuroprotection</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Neuroprotection</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Neuroprotección</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Polymorphisme</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Polymorphism</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Polimorfismo</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Variant</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Variant</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Variante</s0><s5>03</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Variabilité génétique</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Genetic variability</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Variabilidad genética</s0><s5>04</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Génotype</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Genotype</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Genotipo</s0><s5>05</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Génétique</s0><s5>06</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Genetics</s0><s5>06</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Genética</s0><s5>06</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Ubiquitin carboxy-terminal hydrolase L1</s0><s4>INC</s4><s5>88</s5></fC03><fN21><s1>093</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist><affiliations><list><country><li>Canada</li><li>Espagne</li><li>Grèce</li><li>Japon</li><li>Suède</li></country><region><li>Catalogne</li></region><settlement><li>Barcelone</li><li>Tokyo</li></settlement></list><tree><country name="Grèce"><noRegion><name sortKey="Xilouri, Maria" sort="Xilouri, Maria" uniqKey="Xilouri M" first="Maria" last="Xilouri">Maria Xilouri</name></noRegion><name sortKey="Kyratzi, Elli" sort="Kyratzi, Elli" uniqKey="Kyratzi E" first="Elli" last="Kyratzi">Elli Kyratzi</name><name sortKey="Maniati, Matina" sort="Maniati, Matina" uniqKey="Maniati M" first="Matina" last="Maniati">Matina Maniati</name><name sortKey="Papadopoulou Daifoti, Zoi" sort="Papadopoulou Daifoti, Zoi" uniqKey="Papadopoulou Daifoti Z" first="Zoi" last="Papadopoulou-Daifoti">Zoi Papadopoulou-Daifoti</name><name sortKey="Pitychoutis, Pothitos M" sort="Pitychoutis, Pothitos M" uniqKey="Pitychoutis P" first="Pothitos M." last="Pitychoutis">Pothitos M. Pitychoutis</name><name sortKey="Stefanis, Leonidas" sort="Stefanis, Leonidas" uniqKey="Stefanis L" first="Leonidas" last="Stefanis">Leonidas Stefanis</name><name sortKey="Stefanis, Leonidas" sort="Stefanis, Leonidas" uniqKey="Stefanis L" first="Leonidas" last="Stefanis">Leonidas Stefanis</name></country><country name="Espagne"><region name="Catalogne"><name sortKey="Perier, Celine" sort="Perier, Celine" uniqKey="Perier C" first="Celine" last="Perier">Celine Perier</name></region><name sortKey="Vila, Miquel" sort="Vila, Miquel" uniqKey="Vila M" first="Miquel" last="Vila">Miquel Vila</name><name sortKey="Vila, Miquel" sort="Vila, Miquel" uniqKey="Vila M" first="Miquel" last="Vila">Miquel Vila</name><name sortKey="Vila, Miquel" sort="Vila, Miquel" uniqKey="Vila M" first="Miquel" last="Vila">Miquel Vila</name></country><country name="Suède"><noRegion><name sortKey="Ulusoy, Ayse" sort="Ulusoy, Ayse" uniqKey="Ulusoy A" first="Ayse" last="Ulusoy">Ayse Ulusoy</name></noRegion><name sortKey="Kirik, Deniz" sort="Kirik, Deniz" uniqKey="Kirik D" first="Deniz" last="Kirik">Deniz Kirik</name></country><country name="Canada"><noRegion><name sortKey="Park, David S" sort="Park, David S" uniqKey="Park D" first="David S." last="Park">David S. Park</name></noRegion></country><country name="Japon"><noRegion><name sortKey="Wada, Keiji" sort="Wada, Keiji" uniqKey="Wada K" first="Keiji" last="Wada">Keiji Wada</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000121 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000121 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:12-0122767
|texte= Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system
}}
| This area was generated with Dilib version V0.6.29. |  |